Similar articles

• Risk of venous thrombosis with hormone-replacement therapy.

  Vandenbroucke JP, Helmerhorst FM. Vandenbroucke JP, et al. Lancet. 1996 Oct 12;348(9033):972. doi: 10.1016/S0140-6736(05)64918-5. Lancet. 1996. PMID: 8855846 No abstract available.
• Type of hormone replacement therapy and risk of venous thromboembolism.

  Roberts H. Roberts H. BMJ. 2008 May 31;336(7655):1203-4. doi: 10.1136/bmj.39556.666944.80. Epub 2008 May 20. BMJ. 2008. PMID: 18495630 Free PMC article.
• Estrogen and the risk of coagulopathy.

  Lobo RA. Lobo RA. Am J Med. 1992 Mar;92(3):283-5. doi: 10.1016/0002-9343(92)90078-p. Am J Med. 1992. PMID: 1546727 No abstract available.
• [Hormone therapy and risk for venous thromboembolism in postmenopausal women].

  Lacut K, Oger E. Lacut K, et al. Rev Prat. 2005 Feb 28;55(4):389-92. Rev Prat. 2005. PMID: 15828617 Review. French.
• Hormone therapy and risk of venous thromboembolism among postmenopausal women.

  Canonico M, Scarabin PY. Canonico M, et al. Climacteric. 2009;12 Suppl 1:76-80. doi: 10.1080/13697130903006837. Climacteric. 2009. PMID: 19811247 Review.